2019
DOI: 10.1007/s12039-019-1622-9
|View full text |Cite
|
Sign up to set email alerts
|

Potassium iodate ($$\hbox {KIO}_{3}$$) as a novel reagent for the synthesis of isoxazolines: evaluation of antimicrobial activity of the products

Abstract: A novel reagent for the synthesis of isoxazolines has been reported. Aryl aldoximes were made to react with alkenes in the presence of KIO 3 as the oxidising agent. This new reagent has been useful as an oxidant in the synthesis of isoxazoline and its function is attributed to the generation of nitrile oxide, which is an important intermediate for the synthesis of the valuable heterocycle like isoxazoline.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 19 publications
(21 reference statements)
0
3
0
Order By: Relevance
“…for the synthesis of isoxazoline‐based derivatives; these derivatives were screened for their antibacterial activities against Gram‐negative ( K. pneumonia and E. coli ) and Gram‐positive ( B. subtilis and S. aureus ) bacteria. Compound 74 showed outstanding inhibition against both Gram‐negative strains with a MIC value of 0.75 μg mL −1 as compared with the other synthesized compounds [143] . A regiospecific synthesis of isoxazoline chromene derivatives was developed by Ben Jannet and colleagues, and after biological evaluations, compounds 75 , 76 and 77 were found to be potent with MIC=0.03 mg mL −1 toward P. aeruginosa in comparison with the standard drug gentamicin, having MIC=0.5 mg mL −1 (Figure 14).…”
Section: Pharmacological Profile Of Isoxazoline Derivativesmentioning
confidence: 93%
“…for the synthesis of isoxazoline‐based derivatives; these derivatives were screened for their antibacterial activities against Gram‐negative ( K. pneumonia and E. coli ) and Gram‐positive ( B. subtilis and S. aureus ) bacteria. Compound 74 showed outstanding inhibition against both Gram‐negative strains with a MIC value of 0.75 μg mL −1 as compared with the other synthesized compounds [143] . A regiospecific synthesis of isoxazoline chromene derivatives was developed by Ben Jannet and colleagues, and after biological evaluations, compounds 75 , 76 and 77 were found to be potent with MIC=0.03 mg mL −1 toward P. aeruginosa in comparison with the standard drug gentamicin, having MIC=0.5 mg mL −1 (Figure 14).…”
Section: Pharmacological Profile Of Isoxazoline Derivativesmentioning
confidence: 93%
“…Kotain et al synthesized isoxazoline-based derivatives, which were screened for their antibacterial activities. Compound 132 was found to show outstanding inhibition against both tested Gram-negative strains (K. pneumonia and E. coli) 19,[82][83][84][85][86][87][88][89][90] (Figure 12). In order to prepare fluorine-containing compounds, the development of efficient synthetic methods applicable to fluorine-containing organic compounds is necessary.…”
Section: Account Synlettmentioning
confidence: 99%
“…[81] For more than half of a century, both tested Gram-negative strains (K. pneumonia and E. coli). [19,[82][83][84][85][86][87][88][89][90] (Figure 16) Generally, there are two ways of introducing fluorine into organic molecules. First, direct introduction of fluorine atoms by using either nucleophilic or electrophilic agents.…”
Section: Selective Synthesis Of Functionalized Alicycles Through Cros...mentioning
confidence: 99%